N6-Adenosine Methylation (m6A) RNA Modification: an Emerging Role in Cardiovascular Diseases

被引:42
作者
Chen, Ye-shi [1 ]
Ouyang, Xin-ping [2 ,3 ]
Yu, Xiao-hua [4 ]
Novak, Petr [5 ]
Zhou, Le [5 ]
He, Ping-ping [1 ,3 ]
Yin, Kai [5 ]
机构
[1] Univ South China, Sch Nursing, Hengyang 421001, Hunan, Peoples R China
[2] Univ South China, Hengyang Med Coll, Hengyang Key Lab Neurodegenerat & Cognit Impairme, Dept Physiol,Neurosci Inst, Hengyang 421001, Hunan, Peoples R China
[3] Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Hengyang 421001, Hunan, Peoples R China
[4] Hainan Med Univ, Inst Clin Med, Affiliated Hosp 2, Haikou 460106, Hainan, Peoples R China
[5] Guilin Med Univ, Affiliated Hosp 2, Guangxi Key Lab Diabet Syst Med, Guilin 541100, Peoples R China
关键词
Epitranscriptomics; N6-methyladenosine (m(6)A); Methyltransferase; Demethylase; Cardiovascular diseases; MESSENGER-RNA; INSULIN-RESISTANCE; NUCLEAR-RNA; DNA METHYLATION; DEMETHYLASE ALKBH5; GENE-EXPRESSION; HEART-FAILURE; FOOD-INTAKE; FTO; OBESITY;
D O I
10.1007/s12265-021-10108-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
N6-methyladenosine (m(6)A) is the most abundant and prevalent epigenetic modification of mRNA in mammals. This dynamic modification is regulated by m(6)A methyltransferases and demethylases, which control the fate of target mRNAs through influencing splicing, translation and decay. Recent studies suggest that m(6)A modification plays an important role in the progress of cardiac remodeling and cardiomyocyte contractile function. However, the exact roles of m(6)A in cardiovascular diseases (CVDs) have not been fully explained. In this review, we summarize the current roles of the m(6)A methylation in the progress of CVDs, such as cardiac remodeling, heart failure, atherosclerosis (AS), and congenital heart disease. Furthermore, we seek to explore the potential risk mechanisms of m(6)A in CVDs, including obesity, inflammation, adipogenesis, insulin resistance (IR), hypertension, and type 2 diabetes mellitus (T2DM), which may provide novel therapeutic targets for the treatment of CVDs.
引用
收藏
页码:857 / 872
页数:16
相关论文
共 154 条
[21]   N6-Methyladenosine Modification Controls Circular RNA Immunity [J].
Chen, Y. Grace ;
Chen, Robert ;
Ahmad, Sadeem ;
Verma, Rohit ;
Kasturi, Sudhir Pai ;
Amaya, Laura ;
Broughton, James P. ;
Kim, Jeewon ;
Cadena, Cristhian ;
Pulendran, Bali ;
Hur, Sun ;
Chang, Howard Y. .
MOLECULAR CELL, 2019, 76 (01) :96-+
[22]   Potential of anti-inflammatory agents for treatment of atherosclerosis [J].
Chistiakov, Dimitry A. ;
Melnichenko, Alexandra A. ;
Grechko, Andrey V. ;
Myasoedova, Veronika A. ;
Orekhov, Alexander N. .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2018, 104 (02) :114-124
[23]   Neonatal Transplantation Confers Maturation of PSC-Derived Cardiomyocytes Conducive to Modeling Cardiomyopathy [J].
Cho, Gun-Sik ;
Lee, Dong I. ;
Tampakakis, Emmanouil ;
Murphy, Sean ;
Andersen, Peter ;
Uosaki, Hideki ;
Chelko, Stephen ;
Chakir, Khalid ;
Hong, Ingie ;
Seo, Kinya ;
Chen, Huei-Sheng Vincent ;
Chen, Xiongwen ;
Basso, Cristina ;
Houser, Steven R. ;
Tomaselli, Gordon F. ;
O'Rourke, Brian ;
Judge, Daniel P. ;
Kass, David A. ;
Kwon, Chulan .
CELL REPORTS, 2017, 18 (02) :571-582
[24]   Overexpression of Fto leads to increased food intake and results in obesity [J].
Church, Chris ;
Moir, Lee ;
McMurray, Fiona ;
Girard, Christophe ;
Banks, Gareth T. ;
Teboul, Lydia ;
Wells, Sara ;
Bruening, Jens C. ;
Nolan, Patrick M. ;
Ashcroft, Frances M. ;
Cox, Roger D. .
NATURE GENETICS, 2010, 42 (12) :1086-U147
[25]   FTO Obesity Variant Circuitry and Adipocyte Browning in Humans [J].
Claussnitzer, Melina ;
Dankel, Simon N. ;
Kim, Kyoung-Han ;
Quon, Gerald ;
Meuleman, Wouter ;
Haugen, Christine ;
Glunk, Viktoria ;
Sousa, Isabel S. ;
Beaudry, Jacqueline L. ;
Puviindran, Vijitha ;
Abdennur, Nezar A. ;
Liu, Jannel ;
Svensson, Per-Arne ;
Hsu, Yi-Hsiang ;
Drucker, Daniel J. ;
Mellgren, Gunnar ;
Hui, Chi-Chung ;
Hauner, Hans ;
Kellis, Manolis .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (10) :895-907
[26]   m6A mRNA methylation regulates human β-cell biology in physiological states and in type 2 diabetes [J].
De Jesus, Dario F. ;
Zhang, Zijie ;
Kahraman, Sevim ;
Brown, Natalie K. ;
Chen, Mengjie ;
Hu, Jiang ;
Gupta, Manoj K. ;
He, Chuan ;
Kulkarni, Rohit N. .
NATURE METABOLISM, 2019, 1 (08) :765-774
[27]   IDENTIFICATION OF METHYLATED NUCLEOSIDES IN MESSENGER-RNA FROM NOVIKOFF HEPATOMA-CELLS [J].
DESROSIERS, R ;
FRIDERICI, K ;
ROTTMAN, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1974, 71 (10) :3971-3975
[28]   The N6-Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy [J].
Dorn, Lisa E. ;
Lasman, Lior ;
Chen, Jing ;
Xu, Xianyao ;
Hund, Thomas J. ;
Medvedovic, Mario ;
Hanna, Jacob H. ;
van Berlo, Jop H. ;
Accornero, Federica .
CIRCULATION, 2019, 139 (04) :533-545
[29]   YTHDF2 destabilizes m6A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex [J].
Du, Hao ;
Zhao, Ya ;
He, Jinqiu ;
Zhang, Yao ;
Xi, Hairui ;
Liu, Mofang ;
Ma, Jinbiao ;
Wu, Ligang .
NATURE COMMUNICATIONS, 2016, 7
[30]   Crystal Structures of the Human RNA Demethylase Alkbh5 Reveal Basis for Substrate Recognition [J].
Feng, Chong ;
Liu, Yang ;
Wang, Guoqiang ;
Deng, Zengqin ;
Zhang, Qi ;
Wu, Wei ;
Tong, Yufeng ;
Cheng, Changmei ;
Chen, Zhongzhou .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (17) :11571-11583